Nortriptyline Ria (Nortriptyline)

Nortriptyline is a tricyclic antidepressant that modulates neurotransmitter pathways involved in mood and pain perception.

• Major depressive disorder: reduces depressive symptoms and improves mood in adults.
• Depressive episodes: alleviates acute depressive signs during episodic phases.
• Neuropathic pain: provides analgesic relief for chronic nerve‑related pain.
• Chronic tension‑type headache: helps decrease headache frequency and intensity.

• Nortriptyline inhibits the reuptake of norepinephrine and serotonin at neuronal synapses, increasing their extracellular concentrations. This enhances monoaminergic neurotransmission, which contributes to mood elevation and modulation of pain pathways. The drug also exhibits antagonism at certain muscarinic, histamine H1, and alpha‑adrenergic receptors, influencing its side‑effect profile.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Dry mouth: reduced salivary flow causing discomfort.
• Constipation: slowed gastrointestinal motility.
• Drowsiness: increased sedation, especially at treatment initiation.
• Blurred vision: transient visual disturbances.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening.
• Seizures: heightened risk in predisposed individuals.
• Severe hypotension: marked drop in blood pressure upon standing.
• Hepatotoxicity: liver enzyme elevation or injury.
• Agranulocytosis: marked reduction in white blood cells.
• Suicidal thoughts: emergence or worsening of suicidal ideation.

Before initiating nortriptyline, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

• Cardiac assessment: review history of arrhythmias or conduction disorders.
• Blood pressure monitoring: observe for orthostatic hypotension.
• Elderly caution: start at lower doses to reduce fall risk.
• Discontinuation strategy: taper gradually to avoid withdrawal symptoms.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nortriptyline may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Selective serotonin reuptake inhibitors (SSRIs) or SNRIs: potential serotonin syndrome.
• Linezolid: additive serotonergic effects.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, quinidine): increase nortriptyline plasma levels.
• Anticholinergic agents: exacerbate dry mouth and constipation.
• CNS depressants (e.g., alcohol, benzodiazepines): enhance sedation and dizziness.